2022-2023 Seasonal Influenza Vaccine Supply

For Health Care Providers

Purpose

Flu vaccine is produced by private manufacturers, so supply depends on manufacturers. Vaccine manufacturers have projected that they will supply the United States with as many as 173.5 million to 183.5 million doses of influenza vaccines for the 2022-2023 season. These projections may change as the season progresses. All flu vaccines for the 2022-2023 season will be quadrivalent (four component). Most will be thimerosal-free or thimerosal-reduced vaccine (93%), and about 20% of flu vaccines will be egg-free.

Close-up of multiple vaccine vials

Total Doses Distributed

Table of 2022-23 Seasonal Influenza Vaccine — Total Doses Distributed
Week Total Doses Distributed (in millions)
3/4/2023 173.37M
2/25/2023 173.26M
2/18/2023 173.16M
2/11/2023 173.02M
2/4/2023 172.76M
1/28/2023 171.97M
1/21/2023 171.80M
1/14/2023 171.52M
1/7/2023 171.19M
12/31/2022 170.71M
12/10/2022 157.61M
12/3/2022 156.42M
11/26/2022 154.97M
11/19/2022 154.10M
11/12/2022 152.24M
11/5/2022 150.17M
10/29/2022 145.77M
10/22/2022 136.95M
10/15/2022 128.43M
10/8/2022 115.81M
10/1/2022 105.77M
9/24/2022 91.24M
9/17/2022 71.44M
9/10/2022 47.06M
Content Source
Error processing SSI file
About This Page
Published: October 1, 2024
Updated: September 17, 2024

This page was last updated on this date. Updates may include minor edits, image changes, or other modifications to page content.

Reviewed: September 17, 2024

The information on this page was last reviewed by subject matter experts to ensure accuracy.